SB 322 — An Act providing for approval from the Department of Health and the Office of Attorney General before certain transactions involving health care entities within this Commonwealth.

PRINTER'S NO.   817

                    THE GENERAL ASSEMBLY OF PENNSYLVANIA



                        SENATE BILL
                        No. 322
                                               Session of
                                                 2025

     INTRODUCED BY KEARNEY, KANE, CAPPELLETTI, A. WILLIAMS, HAYWOOD,
        SAVAL, COSTA, SCHWANK AND FLYNN, MAY 22, 2025

     REFERRED TO INSTITUTIONAL SUSTAINABILITY AND INNOVATION,
        MAY 22, 2025


                                     AN ACT
 1   Providing for approval from the Department of Health and the
 2      Office of Attorney General before certain transactions
 3      involving health care entities within this Commonwealth.
 4                             TABLE OF CONTENTS
 5   Chapter 1.    Preliminary Provisions
 6   Section 101.    Short title.
 7   Section 102.    Definitions.
 8   Chapter 3.    Covered Health Care Transactions
 9   Section 301.    Transactions against public interest.
10   Section 302.    Filing of transactions.
11   Section 303.    Public input.
12   Section 304.    Determination and restraining prohibited
13                 transactions.
14   Section 305.    Compliance and power of court.
15   Section 306.    Powers and duties of Attorney General.
16   Section 307.    Powers and duties of department.
17   Section 308.    Confidential treatment.
18   Chapter 10.    Miscellaneous Provisions
 1   Section 1001.    Construction.
 2   Section 1002.    Effective date.
 3      The General Assembly of the Commonwealth of Pennsylvania
 4   hereby enacts as follows:
 5                                   CHAPTER 1
 6                           PRELIMINARY PROVISIONS
 7   Section 101.    Short title.
 8      This act shall be known and may be cited as the Health System
 9   Protection Act.
10   Section 102.    Definitions.
11      The following words and phrases when used in this act shall
12   have the meanings given to them in this section unless the
13   context clearly indicates otherwise:
14      "Affected community."       A county within this Commonwealth
15   where an existing health care facility is physically located or
16   a county whose residents are regularly served by the existing
17   health care facility.
18      "Affiliate."    A person that directly or indirectly, through
19   one or more intermediaries, controls or is controlled by, or is
20   under common control with, the person specified.
21      "Against the public interest."         A covered transaction that,
22   as determined by the Attorney General, results in any of the
23   following:
24          (1)     A significant reduction in competition or a
25      significant increase in costs for health care payers,
26      purchasers or consumers.
27          (2)     An unfair method of competition in or affecting
28      health care commerce or an unfair or deceptive act or
29      practice in or affecting health care commerce.
30          (3)     A significant reduction in the quality of care.

20250SB0322PN0817                      - 2 -
 1          (4)    A significant reduction in access to or availability
 2      of health care services for payers, purchasers or consumers.
 3          (5)    A significant reduction in access to care in a
 4      rural, low-income or disadvantaged community.
 5          (6)    A health care leaseback agreement.
 6      "Attorney General."      The Office of Attorney General of the
 7   Commonwealth.
 8      "Capital distribution."      A payment made, liability incurred
 9   or other consideration given by a health care entity to a person
10   for the purchase, acquisition, redemption, repurchase, payment
11   or retirement of capital stock or other equity interest of the
12   health care entity or as a dividend, return of capital or other
13   distribution in respect of the health care entity's capital
14   stock or other equity interest.
15      "Control," "controlled by" or "under common control with."
16   As follows:
17          (1)    The possession, direct or indirect, of the power to
18      direct or cause the direction of the management and policies
19      of a person, whether through the ownership of voting
20      securities, by contract other than a commercial contract for
21      goods or nonmanagement services or otherwise, unless the
22      power is the result of an official position with or corporate
23      office held by the person. Control shall be presumed to exist
24      if a person, directly or indirectly:
25                 (i)    owns more than 10% of a person; or
26                 (ii)    controls, holds with the power to vote or holds
27          proxies representing 10% or more of the votes that all
28          shareholders or members would be entitled to cast in the
29          election of directors or managers.
30          (2)    The presumption under paragraph (1) may be rebutted

20250SB0322PN0817                      - 3 -
 1      by a showing that control does not exist in fact. The
 2      Attorney General may determine, after furnishing all persons
 3      in interest notice and opportunity to be heard and making
 4      specific findings of fact to support the determination, that
 5      control exists in fact, notwithstanding the absence of a
 6      presumption to that effect or that another person has
 7      control.
 8      "Covered entity."   Includes:
 9          (1)    A for-profit entity or an affiliate of a for-profit
10      entity that owns, operates or controls or seeks to own,
11      operate or control a health care entity.
12          (2)    An investor or group of investors who primarily
13      engage in the raising or returning of capital and who invest,
14      develop or dispose of specified assets, a private equity
15      company, a private equity fund or a real estate investment
16      trust or affiliate.
17      "Covered transaction."   A transaction or a series of
18   transactions involving at least one health care entity and one
19   covered entity, and includes any of the following:
20          (1)    The sale, transfer, lease or other encumbrance of a
21      material amount of a health care entity's assets, including
22      real property, employment groups, emergency departments or
23      other units.
24          (2)    A change in control of a health care entity.
25          (3)    A capital distribution or similar reduction of a
26      health care entity's equity capital by a material amount or
27      the incursion of an obligation that commits the health care
28      entity to making a capital distribution or similar reduction
29      of equity by a material amount.
30      "Department."   The Department of Health of the Commonwealth.

20250SB0322PN0817                   - 4 -
 1      "Health care entity."    The term includes:
 2          (1)   A person that directs, or through an affiliate
 3      directs, control of one or more health care facilities.
 4          (2)   A practitioner organization, representing eight or
 5      more health care practitioners, valued at or above a material
 6      amount.
 7      "Health care facility."    The term shall have the same meaning
 8   as in section 802.1 of the act of July 1, 1979 (P.L.130, No.48),
 9   known as the Health Care Facilities Act.
10      "Health care leaseback agreement."     A transaction whereby a
11   person sells, transfers, leases or otherwise encumbers a
12   material amount of the assets or real property of a health care
13   entity and enters into an agreement with another person to lease
14   back the same assets or real property.
15      "Health care practitioner."     The term shall have the same
16   meaning as in section 103 of the Health Care Facilities Act.
17      "Material amount."   An amount equal to $5,000,000 or more.
18      "Practitioner organization."     A person, other than a health
19   care facility, which is in the business of health care delivery
20   or management and that represents health care practitioners in
21   contracting with carriers or third-party administrators for the
22   payment of health care services.
23      "Private equity company."    A nonpublicly traded entity that
24   collects capital investments from individuals or entities.
25      "Private equity fund."    An entity that directly, or through
26   an affiliate, acts as a control person and is any of the
27   following:
28          (1)   A person considered an investment company under 15
29      U.S.C. § 80a-3 (relating to definition of investment
30      company), except for the application of 15 U.S.C. § 80a-3(c)

20250SB0322PN0817                   - 5 -
 1      (1) and (7).
 2            (2)   A venture capital fund as defined in 17 CFR
 3      275.203(l)-1 (relating to venture capital fund defined).
 4            (3)   A sovereign wealth fund.
 5      "Professional licensing board."      A professional licensing
 6   board within the Bureau of Professional and Occupational Affairs
 7   of the Department of State.
 8      "Real estate investment trust."      The term shall have the same
 9   meaning as in 26 U.S.C. § 856 (relating to definition of real
10   estate investment trust).
11                                 CHAPTER 3
12                      COVERED HEALTH CARE TRANSACTIONS
13   Section 301.    Transactions against public interest.
14      (a)   General rule.--Except as provided under subsection (b),
15   a person may not enter into a covered transaction that is
16   against the public interest.
17      (b)   Exception.--An action prohibited under subsection (a)
18   may be permitted when, as determined by the Attorney General,
19   there is no feasible alternative to prevent a health care
20   entity's closure or a greater loss of health care services.
21   Section 302.    Filing of transactions.
22      (a)   Duties of health care entity.--Prior to entering into a
23   covered transaction, a health care entity shall complete one of
24   the following:
25            (1)   file a notification in accordance with subsection
26      (b) and observe the waiting period under subsection (c); or
27            (2)   obtain a written determination from the Attorney
28      General that the covered transaction is not against the
29      public interest.
30      (b)   Notice.--Notification of a covered transaction shall be

20250SB0322PN0817                    - 6 -
 1   submitted to the Attorney General and the department on a form
 2   and in a manner developed by the Attorney General. The
 3   notification shall include all of the following, as applicable:
 4          (1)   All organic documents, including articles of
 5      incorporation, bylaws, operating agreements and other
 6      documents related to governance and ownership of each party.
 7          (2)   All complete transaction documents with attachments,
 8      including collateral or ancillary agreements involving
 9      officers, directors or employees.
10          (3)   All documents signed by the principals, or the
11      principal's agents, that are necessary to determine the
12      proposed transaction's effect, if any, on affiliates, whether
13      nonprofit or for profit.
14          (4)   Any of the following that comprise part or all of
15      the transaction:
16                (i)    Asset contribution agreements.
17                (ii)    Operating agreements.
18                (iii)    Management contracts.
19          (5)   All information necessary to evaluate the effects of
20      the transaction on each component of an integrated delivery
21      system if that transaction involves a hospital, including any
22      changes in contracts between the integrated delivery system
23      entities and related physician groups.
24          (6)   All financial documents of the transaction parties
25      and related entities, if applicable, including audited
26      financial statements, ownership records, business projection
27      data, current capital asset valuation data and any records
28      upon which future earnings, existing asset values and fair
29      market value analysis can be based.
30          (7)   All fairness opinions and independent valuation

20250SB0322PN0817                     - 7 -
 1    reports of the assets and liabilities of the parties,
 2    prepared on the parties' behalf.
 3        (8)     A list of all donor restricted assets, together with
 4    origination documents and current fund balances.
 5        (9)     All relevant contracts that may affect value,
 6    including business contracts and employee contracts, such as
 7    buy-out provisions, profit-sharing agreements and severance
 8    packages.
 9        (10)    All information and representations disclosing
10    related party transactions that are necessary to assess
11    whether the transaction is at arm's length or involves self-
12    dealing.
13        (11)    All documents relating to noncash elements of the
14    transaction, including pertinent valuations of security for
15    loans and stock restrictions.
16        (12)    All tax-related information, including the
17    existence of tax-free debt subject to redemption and
18    disqualified person transactions yielding tax liability.
19        (13)    A list of ongoing litigation, including full court
20    captions, involving the transaction parties or the
21    transaction parties' related entities, that may affect the
22    interests of the parties.
23        (14)    All information in the possession of the
24    transacting parties relative to the perspective of the health
25    care entity's patient base and communities served, or their
26    representatives.
27        (15)    All information, including internal and external
28    reports and studies, bearing on the effect of the proposed
29    transaction on the availability or accessibility of health
30    care in the affected community.

20250SB0322PN0817                  - 8 -
 1            (16)   A complete list of all insurance plans under
 2      contract and the policies' expiration dates.
 3            (17)   Organizational charts of the parties to the
 4      transaction, as they exist both preconsummation and
 5      postconsummation of the transaction, detailing the
 6      relationship between the principal parties, including any
 7      subsidiary.
 8            (18)   All additional documents that the Attorney General
 9      deems necessary for review purposes.
10      (c)   Waiting period.--Prior to entering into a covered
11   transaction, a health care entity shall undergo a 90-day waiting
12   period, which shall begin on the date the Attorney General
13   receives the notification required under subsection (b). Within
14   two business days, the Attorney General shall confirm receipt of
15   the notification with the health care entity that submitted the
16   notification. Upon the expiration of the waiting period provided
17   for under this subsection, and any extension of a waiting period
18   under subsection (d), the covered transaction may proceed unless
19   the Attorney General determines the covered transaction is
20   against the public interest.
21      (d)   Additional information and waiting period extensions.--
22            (1)    The Attorney General may, no later than 30 days
23      prior to the expiration of the waiting period under
24      subsection (c), require the submission of additional
25      information or documentary material from a person who is a
26      party to the proposed covered transaction for which a
27      notification was filed under subsection (b) or from any
28      officer, director, partner, agent or employee of the person.
29            (2)    The Attorney General may, in its discretion, extend
30      the waiting period under subsection (c) for an additional 30

20250SB0322PN0817                     - 9 -
 1      days for a covered transaction after the date on which the
 2      Attorney General receives either of the following from a
 3      person to whom a request is made under paragraph (1):
 4                  (i)    all of the additional information and
 5            documentary material requested; or
 6                  (ii)    if the request is not fully complied with, the
 7            information and documentary material submitted and a
 8            statement of the reasons for the noncompliance.
 9            (3)   Additional extensions of the waiting period beyond
10      what is required under subsection (b) must be granted by a
11      court in accordance with section 305.
12   Section 303.     Public input.
13      (a)   Public hearing.--Prior to the expiration of the
14   respective waiting period under section 302(c), along with any
15   extension granted under section 302(d), the Attorney General may
16   conduct one or more public hearings on the proposed covered
17   transaction.
18      (b)   Accessibility.--
19            (1)   A public hearing required under subsection (a) shall
20      be live-streamed on the Attorney General's publicly
21      accessible Internet website.
22            (2)   A video recording of the public hearing shall be
23      posted on the Attorney General's publicly accessible Internet
24      website.
25      (c)   Specific entities.--If a covered transaction involves
26   the acquisition of a health care facility, the Attorney General
27   may hold a public hearing in any county in which the acquired
28   entity is located to hear comments from interested parties.
29   Interested parties shall include employees of the health care
30   entity, legal aid organizations, public officials and health

20250SB0322PN0817                       - 10 -
 1   advocacy organizations within a county in which the health care
 2   facility is located. The Attorney General may request testimony
 3   at a hearing from State agencies subject to section 306(d).
 4      (d)   Notice.--At least 14 days before the date of the public
 5   hearing, the Attorney General shall provide written notice of
 6   the date, time and place of the public hearing:
 7            (1)   On the Attorney General's publicly accessible
 8      Internet website.
 9            (2)   Through social and broadcast media.
10            (3)   Through publication in one or more newspapers of
11      general circulation in the affected community.
12            (4)   To the governing body of each county in which the
13      health care entity is located.
14      (e)   Substantive changes to proposal.--If a substantive
15   change in the covered transaction is submitted to the Attorney
16   General after the initial public hearing, the Attorney General
17   may conduct an additional public hearing to hear comments from
18   interested parties with respect to the change.
19   Section 304.     Determination and restraining prohibited
20                  transactions.
21      (a)   Determination.--No later than the final date of
22   expiration of the respective waiting period under section
23   302(c), along with any extension granted under section 302(d),
24   the Attorney General shall determine whether the covered
25   transaction is likely to have an impact that is against the
26   public interest.
27      (b)   Department review.--Prior to making a determination
28   whether a covered transaction is against the public interest,
29   the Attorney General shall consult and request feedback from the
30   department regarding the covered transaction's potential impact

20250SB0322PN0817                    - 11 -
 1   on the existing patient base and affected community.
 2      (c)   Action.--If the Attorney General, in consultation with
 3   the department, determines that the proposed covered transaction
 4   is against the public interest under subsection (a), the
 5   Attorney General, on behalf of the Commonwealth, may:
 6            (1)   commence an action in a court of competent
 7      jurisdiction to enjoin the covered transaction; or
 8            (2)   enter into a voluntary agreement with the covered
 9      entity and the health care entity, which shall be filed with
10      Commonwealth Court, that imposes conditions or otherwise
11      mitigates the aspects that make the covered transaction
12      against the public interest.
13      (d)   Monitoring.--
14            (1)   A voluntary agreement entered into under subsection
15      (c) shall include an initial monitoring period of not more
16      than five years. The monitoring period may be extended for
17      additional periods of not more than five years at the
18      discretion of the Attorney General.
19            (2)   The Attorney General shall consult with the
20      department prior to setting the length of the initial
21      monitoring period and any extension.
22            (3)   During the monitoring period, the Attorney General
23      and the department shall monitor, evaluate and assess the
24      covered entity and health care entity's compliance with the
25      terms and conditions of the voluntary agreement.
26      (e)   Costs of monitoring.--
27            (1)   The covered entity shall pay for the costs of the
28      Attorney General and the department's monitoring, evaluation
29      and assessment of the covered entity and health care entity's
30      compliance with the terms and conditions of the voluntary

20250SB0322PN0817                    - 12 -
 1      agreement during a monitoring period established under
 2      subsection (d).
 3            (2)   The Attorney General, in consultation with the
 4      department, shall determine the amount of the compliance
 5      monitoring cost under this subsection, which shall be paid by
 6      the covered entity and placed in an escrow account during the
 7      monitoring period.
 8      (f)   Licensing.--A health care facility's license may not be
 9   revoked, denied, impeded or cited for noncompliance due solely
10   to a filing or review under this chapter.
11   Section 305.    Compliance and power of court.
12      If a person substantially fails to comply with the
13   notification requirement under section 302(a) or any request for
14   the submission of additional information or documentary material
15   under section 302(b) within the respective waiting period under
16   302(c), along with any extension granted under section 302(d),
17   the court may, in its discretion, do any or all of the
18   following:
19            (1)   Order compliance.
20            (2)   Extend the waiting period until there has been
21      substantial compliance.
22            (3)   Grant other equitable relief as the court determines
23      necessary or appropriate.
24   Section 306.    Powers and duties of Attorney General.
25      (a)   Rules and regulations.--The Attorney General, in
26   coordination with the department, shall issue rules and
27   promulgate regulations as may be necessary to carry out and
28   enforce this chapter. The department and the Attorney General
29   shall ensure that the rules and regulations of the department
30   and the Attorney General are not in conflict.

20250SB0322PN0817                       - 13 -
 1    (b)   Contracts.--
 2          (1)   The Attorney General may do any of the following:
 3                (i)    Contract with, share information with and
 4          consult and receive advice from any Federal agency or
 5          Commonwealth agency as the Attorney General deems
 6          appropriate to implement this chapter.
 7                (ii)    At the Attorney General's sole discretion,
 8          contract with experts or consultants to assist in
 9          reviewing the proposed covered transaction.
10          (2)   The cost of a contract entered into under paragraph
11    (1) must be an amount that is reasonable and necessary to
12    conduct the review and evaluation and in accordance with the
13    following:
14                (i)    A contract may be on a noncompetitive bid basis.
15                (ii)    Upon request, the Attorney General shall be
16          paid promptly for all contract costs by the entities
17          seeking approval or the covered transaction.
18          (3)   The Attorney General shall be entitled to
19    reimbursement from the entities seeking consent for the
20    covered transaction for all actual, reasonable and direct
21    costs incurred in reviewing, evaluating and making a
22    determination under section 304(a), including administrative
23    costs. The entities seeking consent shall promptly pay the
24    Attorney General, upon request, for the costs.
25          (4)   Notwithstanding the other provisions of this act, a
26    covered transaction may not be completed unless an agreement
27    has been executed between the Attorney General and the
28    covered entity, the health care entity or both for the
29    payment of costs in accordance with this subsection.
30    (c)   Compliance.--If a covered entity or health care entity

20250SB0322PN0817                     - 14 -
 1   enters into a voluntary agreement with the Commonwealth under
 2   section 304(c)(2):
 3            (1)   The Attorney General shall monitor, assess and
 4      evaluate a covered entity and health care entity to ensure
 5      compliance with the terms and conditions of the voluntary
 6      agreement for the duration of the monitoring period
 7      established under section 304(d).
 8            (2)   The Attorney General may request documents and other
 9      information from a covered entity or a health care entity, or
10      both, to monitor compliance with the terms of the voluntary
11      agreement under section 304(c). Upon receiving a request from
12      the department, a covered entity or health care entity shall
13      comply with the request within 30 days.
14            (3)   If the Attorney General determines that the health
15      care entity or covered entity has failed to comply with terms
16      of the voluntary agreement, the Attorney General may seek
17      immediate relief in Commonwealth Court to enforce the
18      conditions of the voluntary agreement and may impose any
19      penalties authorized by law or the terms of the voluntary
20      agreement.
21      (d)   Agency cooperation.--
22            (1)   The department, the Department of Aging, the
23      Department of Human Services and the Insurance Department
24      shall assist the Attorney General in reviewing the proposed
25      agreement and transaction, if requested, and shall comply
26      with any request for testimony or information as may be
27      necessary and appropriate for the Attorney General to review
28      a proposed covered transaction.
29            (2)   The Attorney General shall comply with any request
30      for information from the Insurance Department as may be

20250SB0322PN0817                     - 15 -
 1      necessary and appropriate for the Insurance Department to
 2      concurrently review a proposed transaction under Article XIV
 3      of the act of May 17, 1921 (P.L.682, No.284), known as The
 4      Insurance Company Law of 1921. Documents provided by the
 5      Attorney General to the Insurance Department under this
 6      paragraph shall be treated as confidential and are exempt
 7      from public access under the act of February 14, 2008 (P.L.
 8      6, No.3), known as the Right-to-Know Law.
 9            (3)   The Attorney General shall comply with any request
10      for information from the department as may be necessary and
11      appropriate to concurrently review a proposed transaction
12      under the act of July 19, 1979 (P.L.140, No.48), known as the
13      Health Care Facilities Act. Documents provided by the
14      Attorney General to the department under this paragraph shall
15      be treated as confidential and are exempt from public access
16      under the Right-to-Know Law.
17   Section 307.    Powers and duties of department.
18      (a)   Rules and regulations.--The department, in coordination
19   with the Attorney General, shall issues rules and promulgate
20   regulations as may be necessary to carry out and enforce this
21   chapter. The department and the Attorney General shall ensure
22   that the rules and regulations of the department and the
23   Attorney General are not in conflict.
24      (b)   Compliance.--If a health care facility or covered entity
25   enters into a voluntary agreement with the Commonwealth under
26   section 304(c):
27            (1)   The department shall monitor, assess and evaluate a
28      health care facility and covered entity to ensure compliance
29      with the terms and conditions of the voluntary agreement. If
30      the department determines the health care facility or covered

20250SB0322PN0817                    - 16 -
 1      entity has failed to comply with terms of the voluntary
 2      agreement, the department shall immediately notify the
 3      Attorney General of its findings.
 4             (2)   The department may request documents and other
 5      information from a covered entity, a health care facility or
 6      both to monitor compliance with the terms of the voluntary
 7      agreement under section 304(c). Upon receiving a request from
 8      the department, a covered entity or health care facility
 9      shall comply with the request within 30 days.
10             (3)   The department shall be reimbursed from an escrow
11      account established under section 304(e) for costs related to
12      the ongoing monitoring, assessment and evaluation of a health
13      care facility and covered entity's compliance with the terms
14      and conditions of the voluntary agreement during the
15      monitoring period.
16   Section 308.     Confidential treatment.
17      (a)    Confidentiality.--All information, documents, materials
18   and copies thereof in the possession or control of the Attorney
19   General or the department that are produced for, obtained by or
20   disclosed to the Attorney General or the department in the
21   course of a covered entity or health care entity complying with
22   the requirements of section 302(b), 306(c) or (d) or 307(b)
23   shall be privileged and given confidential treatment and shall
24   not be:
25             (1)   Subject to discovery or admissible in evidence in a
26      private civil action.
27             (2)   Subject to subpoena.
28             (3)   Subject to the act of February 14, 2008 (P.L.6,
29      No.3), known as the Right-to-Know Law.
30             (4)   Made public by the Attorney General, the department

20250SB0322PN0817                     - 17 -
 1      or any other person, except to regulatory or law enforcement
 2      officials of this Commonwealth or other jurisdictions or
 3      experts or consultants under contract with the Attorney
 4      General under section 306(b), without the prior written
 5      consent of the health care entity or covered entity to which
 6      it pertains, unless the Attorney General, after giving the
 7      health entity or covered entity that would be affected notice
 8      and opportunity to be heard, determines that the interest of
 9      the public is served by the publication, in which event it
10      may publish all or any part in such manner as it may deem
11      appropriate.
12      (b)   Testifying in a civil action.--The Attorney General, the
13   department, any other Commonwealth agency or any individual or
14   person, who receives documents, materials or other information,
15   while acting under the authority of the Attorney General or the
16   department, or with whom the documents, materials or other
17   information are shared under this chapter, shall not be
18   permitted or required to testify in any private civil action
19   concerning any confidential documents, materials or information
20   covered under this section.
21                                 CHAPTER 10
22                          MISCELLANEOUS PROVISIONS
23   Section 1001.    Construction.
24      This act shall not be construed to:
25            (1)   Narrow, abrogate or otherwise alter the authority of
26      the Attorney General to maintain competitive markets and
27      prosecute or enforce violations of antitrust and unfair trade
28      practices laws.
29            (2)   Narrow, abrogate or otherwise alter the authority of
30      the department to oversee and approve or disapprove the

20250SB0322PN0817                     - 18 -
 1      change of ownership of or regulate a health care facility
 2      under the act of July 1, 1979 (P.L.130, No.48), known as the
 3      Health Care Facilities Act.
 4          (3)   Narrow, abrogate or otherwise alter the authority of
 5      a professional licensing board to issue, suspend or revoke a
 6      health care practitioners license or regulate the practice of
 7      the health arts in this Commonwealth.
 8          (4)   Prohibit a Federal agency, Commonwealth agency or
 9      other state agency from regulating a covered transaction or
10      joining as party in an action seeking to enjoin a covered
11      transaction, including the Insurance Department's
12      jurisdiction to review an exposed transaction under Article
13      XIV of the act of May 17, 1921 (P.L.682, No.284), known as
14      The Insurance Company Law of 1921.
15   Section 1002.   Effective date.
16      This act shall take effect in 60 days.




20250SB0322PN0817                  - 19 -